Curi RMB Capital’s DexCom DXCM Stock Holding History

Curi RMB Capital’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$516K	Sell	7,666 -57	-0.7%	-$3.8K	0.01%	596
2026 Q1	$485K	Buy	7,723 +21	+0.3%	+$1.46K	0.01%	609
2025 Q4	$511K	Buy	+7,702	New	+$498K	0.01%	602

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Curi RMB Capital's DXCM Position: Q2 2026 in Review

Curi RMB Capital reduced its DexCom (DXCM) stake by 0.74% in Q2 2026, selling an estimated $3.8K and leaving 7,666 shares worth $516K. The position accounts for 0.01% of the portfolio, ranked #596.

Curi RMB Capital first reported a position in DXCM in Q4 2025 and has held it in 3 quarters since. 975 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Curi RMB Capital held 7,666 shares of DexCom worth $516K as of Q2 2026.
Curi RMB Capital sold 57 DexCom shares in Q2 2026, an estimated $3.8K.
DexCom made up 0.01% of Curi RMB Capital's portfolio in Q2 2026, its #596 holding.
Curi RMB Capital first reported a position in DexCom in Q4 2025 and has held it in 3 quarters since.
975 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Curi RMB Capital's 13F filing for Q2 2026, filed 14 Aug 2026.